Inside the world of cell therapies

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options. Discover the current market for cancer cell therapies and what biotechs are working on next.


  • Roche digs into off-the-shelf cell therapy with Poseida deal
  • Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use
  • Versant-backed startup launches with plans to broaden cell therapy’s reach



Share the Post:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to our use of all cookies, however, you may visit “Cookies Setting” to provide a controlled consent.

Privacy Policy